Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases

Alen Krajnc, Jürgen Brem, Philip Hinchliffe, Karina A Calvopina, Tharindi D Panduwawala, Pauline Lang, Jos J.A.G. Kamps, Jonathan M Tyrrell, Emma Widlake, Benjamin G Saward, Timothy R Walsh, James Spencer, Christopher J Schofield

Research output: Contribution to journalArticle (Academic Journal)

35 Citations (Scopus)
205 Downloads (Pure)


The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not observed. Crystallography reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1. The crystallographic results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species. The structures imply conserved binding of the bicyclic core with SBLs/MBLs. With NDM-1, by crystallography, we observed an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core. Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization. The results further support the “high-energy-intermediate” analogue approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes.
Original languageEnglish
Pages (from-to)8544-8556
Number of pages13
JournalJournal of Medicinal Chemistry
Issue number18
Publication statusPublished - 27 Aug 2019

Structured keywords

  • BrisSynBio
  • Bristol BioDesign Institute


  • Synthetic biology

Fingerprint Dive into the research topics of 'Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases'. Together they form a unique fingerprint.

  • Projects

    Cite this

    Krajnc, A., Brem, J., Hinchliffe, P., Calvopina, K. A., Panduwawala, T. D., Lang, P., Kamps, J. J. A. G., Tyrrell, J. M., Widlake, E., Saward, B. G., Walsh, T. R., Spencer, J., & Schofield, C. J. (2019). Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases. Journal of Medicinal Chemistry, 62(18), 8544-8556.